Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Bladder Cancer

Free Subscription 30.10.2023 1 Am J Med 1 Ann Oncol 1 Ann Surg Oncol 1 Arch Esp Urol 1 Asian J Surg 1 Biochem Pharmacol 1 BJU Int 1 BMC Cancer 1 BMC Med Genomics 1 BMC Urol 1 Cancer Biol Ther 1 Cancer Cell Int 1 Cancer Commun (Lond) 1 Cancer Immunol Immunother 1 Cancer Med 1 Cancer Rep (Hoboken) 2 Clin Cancer Res 2 Clin Genitourin Cancer 1 Clin Transl Oncol 1 Cochrane Database Syst Rev 4 Eur Urol 1 Eur Urol Oncol 1 Fetal Pediatr Pathol 1 Front Oncol 1 Heliyon 1 IEEE Trans Biomed Eng 2 Int J Urol 2 Int Urol Nephrol 1 Intern Med 1 iScience 1 J Biochem Mol Toxicol 2 J Cancer Res Clin Oncol 1 J Clin Ultrasound 1 J Int Med Res 1 J Pharm Biomed Anal 1 Klin Onkol 1 Mikrobiyol Bul 1 Mol Cell Proteomics 2 Nat Rev Dis Primers 1 Prog Urol 1 Quant Imaging Med Surg 1 Ugeskr Laeger 1 Updates Surg 1 Urol Oncol 1 Urol Pract 3 Urol Res Pract 3 Urologiia 2 Urology 2 World J Oncol 1 World J Surg Oncol 9 World J Urol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. NAGASAKI N, Watanabe T, Edamura K, Araki M, et al
   Bladder Tumors with Multiple Cardiac Metastases, with Elevated Serum Granulocyte Colony-Stimulating Factor.
   Am J Med. 2023;136:e161-e162.
   PubMed        
   
   

   
   Ann Oncol

2. CATTO JWF, Tran B, Roupret M, Gschwend JE, et al
   Erdafitinib in BCG-treated high-risk non-muscle invasive bladder cancer.
   Ann Oncol. 2023 Oct 5:S0923-7534(23)04015-2. doi: 10.1016/j.annonc.2023.09.3116.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. HAM WS, Park JS, Jang WS, Kim J, et al
   Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer.
   Ann Surg Oncol. 2023 Oct 26. doi: 10.1245/s10434-023-14449.
   PubMed         Abstract available
   
   

   
   Arch Esp Urol

4. ZHANG X, Liu Q
   Systemic Immune Inflammation Index and T-Staging Predict Prognosis in Patients with Muscle-Invasive Bladder Cancer.
   Arch Esp Urol. 2023;76:511-518.
   PubMed         Abstract available
   
   

   
   Asian J Surg

5. CHEN YT, Yeh HC, Lee HY, Hsieh PF, et al
   Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study.
   Asian J Surg. 2023;46:3058-3065.
   PubMed         Abstract available
   
   

   
   Biochem Pharmacol

6. WU J, Guo Q, Li J, Yuan H, et al
   Loperamide induces protective autophagy and apoptosis through the ROS/JNK signaling pathway in bladder cancer.
   Biochem Pharmacol. 2023;218:115870.
   PubMed         Abstract available
   
   

   
   BJU Int

7. MCELREE IM, Mott SL, O'Donnell MA, Packiam VT, et al
   Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer.
   BJU Int. 2023 Oct 19. doi: 10.1111/bju.16208.
   PubMed        
   
   

   
   BMC Cancer

8. CHEN JX, Huang WT, Zhang QY, Deng CE, et al
   The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer.
   BMC Cancer. 2023;23:1018.
   PubMed         Abstract available
   
   

   
   BMC Med Genomics

9. SHEN C, Bi Y, Chai W, Zhang Z, et al
   Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer.
   BMC Med Genomics. 2023;16:264.
   PubMed         Abstract available
   
   

   
   BMC Urol

10. HAO L, Mu D, Mu H
    Sakuranin represses the malignant biological behaviors of human bladder cancer cells by triggering autophagy via activating the p53/mTOR pathway.
    BMC Urol. 2023;23:170.
    PubMed         Abstract available
    
    

    
    Cancer Biol Ther

11. WANG Z, Wei B, Ma S
    EGR1/LINC00839/SOX5 axis modulates migration, invasion and Gemcitabine resistance of bladder cancer cells.
    Cancer Biol Ther. 2023;24:2270106.
    PubMed         Abstract available
    
    

    
    Cancer Cell Int

12. FAROUK SM, Khafaga AF, Abdellatif AM
    Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics.
    Cancer Cell Int. 2023;23:251.
    PubMed         Abstract available
    
    

    
    Cancer Commun (Lond)

13. WANG X, Juncker-Jensen A, Huang G, Nagy ML, et al
    Spatial relationship of tertiary lymphoid structures and tumor-associated neutrophils in bladder cancer and prognostic potential for anti-PD-L1 immunotherapy.
    Cancer Commun (Lond). 2023 Oct 20. doi: 10.1002/cac2.12491.
    PubMed        
    
    

    
    Cancer Immunol Immunother

14. FIALA O, Buti S, Takeshita H, Okada Y, et al
    Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
    Cancer Immunol Immunother. 2023;72:3665-3682.
    PubMed         Abstract available
    
    

    
    Cancer Med

15. YANG K, Yu W, Liu H, Lou F, et al
    Mutational pattern off homologous recombination repair (HRR)-related genes in upper tract urothelial carcinoma.
    Cancer Med. 2023;12:15304-15316.
    PubMed         Abstract available
    
    

    
    Cancer Rep (Hoboken)

16. SU PJ, Xiao Y, Lin AY, Goh C, et al
    A cost-effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first-line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan.
    Cancer Rep (Hoboken). 2023;6:e1887.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

17. MITRA A, Thompson B, Strange A, Amato CM, et al
    A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
    Clin Cancer Res. 2023;29:4242-4255.
    PubMed         Abstract available
    
    
18. KAMRAN SC, Zhou Y, Otani K, Drumm M, et al
    Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.
    Clin Cancer Res. 2023 Oct 19. doi: 10.1158/1078-0432.CCR-23-0792.
    PubMed         Abstract available
    
    

    
    Clin Genitourin Cancer

19. KOBAYASHI Y, Arai H, Hamamoto Y, Yoshida K, et al
    High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy.
    Clin Genitourin Cancer. 2023;21:e386-e393.
    PubMed         Abstract available
    
    
20. DOUGLAWI A, Ghoreifi A, Carbonara U, Yip W, et al
    Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group.
    Clin Genitourin Cancer. 2023;21:563-568.
    PubMed         Abstract available
    
    

    
    Clin Transl Oncol

21. MORALES-BARRERA R, Villacampa G, Vidal N, Figols M, et al
    Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment.
    Clin Transl Oncol. 2023;25:3556-3564.
    PubMed         Abstract available
    
    

    
    Cochrane Database Syst Rev

22. MAISCH P, Hwang EC, Kim K, Narayan VM, et al
    Immunotherapy for advanced or metastatic urothelial carcinoma.
    Cochrane Database Syst Rev. 2023;10:CD013774.
    PubMed         Abstract available
    
    

    
    Eur Urol

23. MARTINI A, Falagario UG, Russo A, Mertens LS, et al
    Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in Males.
    Eur Urol. 2023;84:484-490.
    PubMed         Abstract available
    
    
24. MEEKS JJ, Black PC, Galsky M, Grivas P, et al
    Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection.
    Eur Urol. 2023;84:473-483.
    PubMed         Abstract available
    
    
25. SWINTON M, Hoskin P, Choudhury A
    Reply to Thomas Seisen, Morgan Roupret, Quoc-Dien Trinh, and Joaquim Bellmunt's Letter to the Editor re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alterna
    Eur Urol. 2023 Oct 19:S0302-2838(23)03162-7. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    
26. SEISEN T, Roupret M, Trinh QD, Bellmunt J, et al
    Re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J
    Eur Urol. 2023 Oct 19:S0302-2838(23)03163-9. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    

    
    Eur Urol Oncol

27. TAN X, Liu Z, Cai T, Wang Y, et al
    Prognostic Significance of HER2 Expression in Patients with Bacillus Calmette-Guerin-exposed Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Oct 24:S2588-9311(23)00219.
    PubMed         Abstract available
    
    

    
    Fetal Pediatr Pathol

28. CHEIKHROUHOU T, Ben Dhaou M, Charfi S, Hbaieb M, et al
    Phyllodes Tumor of the Bladder in a 2-Year-Old Boy - An Exceptional Finding.
    Fetal Pediatr Pathol. 2023;42:699-705.
    PubMed         Abstract available
    
    

    
    Front Oncol

29. ZHANG X, Huang W, Huang T, Zhang J, et al
    Integrative analysis of triphenyl phosphate: contextual interpretation of bladder cancer cohort.
    Front Oncol. 2023;13:1260114.
    PubMed         Abstract available
    
    

    
    Heliyon

30. KHAN SM, Das T, Chakraborty S, Choudhury AMAR, et al
    A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer.
    Heliyon. 2023;9:e21058.
    PubMed         Abstract available
    
    

    
    IEEE Trans Biomed Eng

31. LAZO JF, Rosa B, Catellani M, Fontana M, et al
    Semi-Supervised Bladder Tissue Classification in Multi-Domain Endoscopic Images.
    IEEE Trans Biomed Eng. 2023;70:2822-2833.
    PubMed         Abstract available
    
    

    
    Int J Urol

32. TABATA H, Tanaka T, Shindo T, Hashimoto K, et al
    Urethrectomy via parapenile incision to complete robot-assisted radical cystectomy in a spine position for male patients.
    Int J Urol. 2023;30:936-938.
    PubMed        
    
    
33. SOMIYA S, Kobori G, Ito K, Nakagawa H, et al
    Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi-institutional cohort.
    Int J Urol. 2023;30:853-858.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

34. WEI C, Deng C, Dong R, Hou Y, et al
    Multi-omics analysis reveals critical metabolic regulators in bladder cancer.
    Int Urol Nephrol. 2023 Oct 26. doi: 10.1007/s11255-023-03841.
    PubMed         Abstract available
    
    
35. PAZIR Y, Esmeray A, Caglar U, Erbin A, et al
    Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette-Guerin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis.
    Int Urol Nephrol. 2023 Oct 25. doi: 10.1007/s11255-023-03849.
    PubMed         Abstract available
    
    

    
    Intern Med

36. MATSUZAWA ADACHI M, Sugawara H, Ishii A, Chiba E, et al
    Malignancy-related Hypercalcemia Caused by Metameric Cutaneous Metastasis of Parathyroid Hormone-related Protein-producing Bladder Carcinoma with Squamous Cell Differentiation: An Autopsy Case of Cobb Syndrome.
    Intern Med. 2023 Mar 1. doi: 10.2169/internalmedicine.0893.
    PubMed         Abstract available
    
    

    
    iScience

37. ZHANG Z, Wang Y, Liang Z, Meng Z, et al
    Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression.
    iScience. 2023;26:108142.
    PubMed         Abstract available
    
    

    
    J Biochem Mol Toxicol

38. WENG M, Deng Z, Huang S, Lin X, et al
    Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo.
    J Biochem Mol Toxicol. 2023 Oct 23:e23556. doi: 10.1002/jbt.23556.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

39. QIU J, Deng R, Yu C, Gong K, et al
    The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.
    J Cancer Res Clin Oncol. 2023;149:14869-14878.
    PubMed         Abstract available
    
    
40. LIU J, Lai S, Wu P, Wang J, et al
    Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.
    J Cancer Res Clin Oncol. 2023;149:10893-10909.
    PubMed         Abstract available
    
    

    
    J Clin Ultrasound

41. SRETENOVIC M, Bojanic N, Grozdic Milojevic I, Bumbasirevic U, et al
    Diagnostic and prognostic impact of preoperative thrombocytosis in muscle invasive bladder cancer: Any role in clinical practice?
    J Clin Ultrasound. 2023 Oct 26. doi: 10.1002/jcu.23600.
    PubMed         Abstract available
    
    

    
    J Int Med Res

42. WEI Y, Yang X, Zhu H, Zhuang J, et al
    Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study.
    J Int Med Res. 2023;51:3000605231204465.
    PubMed         Abstract available
    
    

    
    J Pharm Biomed Anal

43. WAN S, Li KP, Wang CY, Chen SY, et al
    Exploring potential targets of HPV&BC based on network pharmacology and urine proteomics.
    J Pharm Biomed Anal. 2023;236:115694.
    PubMed         Abstract available
    
    

    
    Klin Onkol

44. BERKOVA A, Chovanec Z, Krejcova I, Katolicka J, et al
    A rare case of urothelial carcinoma metastasizing to the gallbladder wall with manifestations as acute cholecystitis.
    Klin Onkol. 2023;36:401-404.
    PubMed         Abstract available
    
    

    
    Mikrobiyol Bul

45. GOZUKUCUK R, Cakiroglu B
    [Miliary Pulmonary Tuberculosis After Intravesical BCG Instillation in a Patient with High-Grade Bladder Cancer].
    Mikrobiyol Bul. 2023;57:675-681.
    PubMed         Abstract available
    
    

    
    Mol Cell Proteomics

46. XIA Y, Xiang L, Yao M, Ai Z, et al
    Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis.
    Mol Cell Proteomics. 2023 Oct 20:100672. doi: 10.1016/j.mcpro.2023.100672.
    PubMed         Abstract available
    
    

    
    Nat Rev Dis Primers

47. DYRSKJOT L, Hansel DE, Efstathiou JA, Knowles MA, et al
    Bladder cancer.
    Nat Rev Dis Primers. 2023;9:58.
    PubMed         Abstract available
    
    
48. 
    Bladder cancer.
    Nat Rev Dis Primers. 2023;9:59.
    PubMed        
    
    

    
    Prog Urol

49. GABRIEL PE, Lambert T, Dumont C, Gauthier H, et al
    [Preoperative chemotherapy for patients with upper tract urothelial carcinoma: Impact on renal function].
    Prog Urol. 2023;33.
    PubMed         Abstract available
    
    

    
    Quant Imaging Med Surg

50. LI B, Li X, Li Z, Yang P, et al
    Magnetic resonance radiographic features which might lead to misdiagnosis of muscle-invasive bladder cancer based on vesical imaging reporting and data system: the application experience of a single center.
    Quant Imaging Med Surg. 2023;13:7258-7268.
    PubMed         Abstract available
    
    

    
    Ugeskr Laeger

51. GOTFREDSEN K, Jandorf S, Zangenberg M, Faber C, et al
    [Not Available].
    Ugeskr Laeger. 2023;185:V04230244.
    PubMed         Abstract available
    
    

    
    Updates Surg

52. WANG X, Wang Y, Che X, Zhou Z, et al
    The prognosis and safety of continuous saline bladder irrigation in patients after transurethral resection of bladder tumors: a systematic review and meta-analysis of comparative study.
    Updates Surg. 2023;75:1795-1806.
    PubMed         Abstract available
    
    

    
    Urol Oncol

53. LI R, Naidu S, Fan W, Rose K, et al
    Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer.
    Urol Oncol. 2023 Oct 23:S1078-1439(23)00332.
    PubMed         Abstract available
    
    

    
    Urol Pract

54. WHITE RE, Linscott JA, Hayn MT, Ryan ST, et al
    Distance to Treatment With Radical Cystectomy in a Rural State: Long Car Rides, Equivalent Outcomes.
    Urol Pract. 2023;10:588-594.
    PubMed         Abstract available
    
    

    
    Urol Res Pract

55. UCHIDA Y, Yokoyama M, Fujiwara M, Nakamura Y, et al
    Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer.
    Urol Res Pract. 2023;49:162-168.
    PubMed         Abstract available
    
    
56. ALKANLI N, Ay A
    Investigation of the Roles of MTHFR (C677T and A1298C) and MMP-2 (-1306C>T ) Variations in Bladder Cancer Development.
    Urol Res Pract. 2023;49:33-39.
    PubMed         Abstract available
    
    
57. EFILOGLU O, Cakici MC, Kir G, Iplikci A, et al
    The Impact of Histological Variants on Oncological Outcomes in Patients with Muscle Invasive Bladder Cancer Treated with Radical Cystectomy.
    Urol Res Pract. 2023;49:246-252.
    PubMed         Abstract available
    
    

    
    Urologiia

58. KURBANOV AA, Kryukov SR, Chernov DV, Votyakov AY, et al
    [Robot-assisted left-side partial nephrectomy with a segmental resection of left lower ureter and Boari reconstruction].
    Urologiia. 2023;:125-128.
    PubMed         Abstract available
    
    
59. KOLPACINIDI FG, Sergeev VP, Kyzlasov PS, Volokitin EV, et al
    [Experience of using Experience of using NefroBest-N for rehabilitation of patients undergoing radical laparoscopic cystectomy].
    Urologiia. 2023;:62-68.
    PubMed         Abstract available
    
    
60. DAMIEV AD, Shpot EV, Akopyan GN, Dymov AM, et al
    [Carboxycryobiopsy and carboxycryoextraction of bladder tumor. Experimental study].
    Urologiia. 2023;:24-29.
    PubMed         Abstract available
    
    

    
    Urology

61. HYLLESTED E, Vejlgaard M, Stroomberg HV, Maibom SL, et al
    Reply by Authors: Acute Kidney Injury Within 90Days of Radical Cystectomy for Bladder Cancer: Incidence and Risk Factors.
    Urology. 2023 Oct 21:S0090-4295(23)00810-5. doi: 10.1016/j.urology.2023.
    PubMed        
    
    
62. GRECO F, Domanico L, Lembo F
    Editorial Comment to Acute Kidney Injury Within 90Days of Radical Cystectomy for Bladder Cancer: Incidence and Risk Factors.
    Urology. 2023 Oct 21:S0090-4295(23)00809-9. doi: 10.1016/j.urology.2023.
    PubMed        
    
    

    
    World J Oncol

63. KIM HJ, Kim KH, Lee SW, Swan H, et al
    Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study.
    World J Oncol. 2023;14:382-391.
    PubMed         Abstract available
    
    
64. WARLI SM, Prapiska FF, Siregar DIS, Seja IA, et al
    Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy.
    World J Oncol. 2023;14:423-429.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

65. LUO Z, Yan Y, Jiao B, Huang T, et al
    Prognostic value of the systemic immune-inflammation index in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    World J Surg Oncol. 2023;21:337.
    PubMed         Abstract available
    
    

    
    World J Urol

66. SONG Y, Peng Y, Xu T
    Letter to the editor for the article "Molecular urothelial tumor cell subtypes remain stable during metastatic evolution".
    World J Urol. 2023;41:2869-2870.
    PubMed        
    
    
67. BANDARA NA, Zhou XR, Alhamam A, Black PC, et al
    The genitourinary impacts of electronic cigarette use: a systematic review of the literature.
    World J Urol. 2023;41:2637-2646.
    PubMed         Abstract available
    
    
68. GUVEN S, Colecchia M, Oltulu P, Bonfante G, et al
    How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey.
    World J Urol. 2023;41:2617-2625.
    PubMed         Abstract available
    
    
69. DIANA P, Gallioli A, Fontana M, Territo A, et al
    Energy source comparison in en-bloc resection of bladder tumors: subanalysis of a single-center prospective randomized study.
    World J Urol. 2023;41:2591-2597.
    PubMed         Abstract available
    
    
70. BREDA A, Gallioli A, Diana P, Fontana M, et al
    The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial.
    World J Urol. 2023;41:2583-2589.
    PubMed         Abstract available
    
    
71. HERRMANN TRW
    En bloc resection of bladder tumors (ERBT) revisited 12 years after reintroduction: too good to be further ignored.
    World J Urol. 2023;41:2577-2582.
    PubMed         Abstract available
    
    
72. GALLIOLI A, Basile G, Territo A, Verri P, et al
    The importance of second-look ureteroscopy implementation in the conservative management of upper tract urothelial carcinoma.
    World J Urol. 2023;41:2743-2749.
    PubMed         Abstract available
    
    
73. ENIKEEV D, Morozov A, Shpikina A, Fajkovic H, et al
    A 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough?
    World J Urol. 2023;41:2607-2615.
    PubMed         Abstract available
    
    
74. TEOH JY, D'Andrea D, Gallioli A, Yanagisawa T, et al
    En bloc resection of bladder tumour: the rebirth of past through reminiscence.
    World J Urol. 2023;41:2599-2606.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.